Drawing for VITRUVIAN

USPTO serial 87031696

VITRUVIAN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
YOO, JEANE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VITRUVIAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cindy M. Zelson

CINDY M. ZELSON General Electric Company901 Main Avenue (Trademarks: 801-4)Corporate Trademark OperationNorwalk, CT 06851

Goods and services

ClassDescriptionStatusFirst use
001Assays for research purposes; assays and reagents for use in genetic researchACTIVE
009Downloadable computer software for ordering, scheduling, tracking, production, manufacturing, business intelligence, and delivery of custom cell and gene therapies; downloadable cloud-computing software for ordering, tracking, scheduling, production, manufacturing, business intelligence, and delivery of custom cell and gene therapiesACTIVE
035Operating an online-marketplace featuring cell and gene therapy treatments and services; business consulting services, namely, data analytics for others in the fields of cell and gene therapiesACTIVE
040Bio manufacturing for others, namely, manufacturing of cell and gene therapies using biological organisms in the manufacturing process; contract manufacturing in the fields of cell and gene therapiesACTIVE
042Software as a service (SAAS) services, namely, hosting software for use by others for ordering, tracking, scheduling, production, manufacturing, business intelligence, and delivery of custom cell and gene therapies; Providing a website featuring non-downloadable software for ordering, tracking, scheduling, production, manufacturing, business intelligence, and delivery of custom cell and gene therapies; Custom design and development of chemical reagents and biochemical assaysACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 10, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 10, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 6, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 12, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 11, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 11, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 21, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 6, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 2, 2016ALIEASSIGNED TO LIE
Aug 17, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 12, 2016XAECEXAMINER'S AMENDMENT ENTERED
Aug 12, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 12, 2016GNEAEXAMINERS AMENDMENT E-MAILED
Aug 12, 2016CNEAEXAMINERS AMENDMENT -WRITTEN
Aug 8, 2016DOCKASSIGNED TO EXAMINER
May 13, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 13, 2016NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance